Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metex pre-filled methotrexate injection vs methotrexate tablets in rheumatoid arthritis
CTR20220043Phase 3Completed
- Sponsor
- medac GmbH
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methotrexate in rheumatoid arthritis (RA) (2 arms), sponsored by medac GmbH. Primary endpoint: Change from baseline in DAS28-ESR at Week 12. Started Jan 2022; status: completed.
02
Drugs
methotrexate
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20220043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220043.